The diagnosis of an HCV infection was made on the basis of the presence of anti-HCV antibodies (Ortho HCV 3.0 ELISA test system with Enhanced SAVe, Ortho Clinical Diagnostics, Raritan, NJ, USA) and ...

The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...

Notably, the patent for daclatasvir will expire before other DAAs. Promoting the use of sofosbuvir–daclatasvir has the potential to lower costs and expand access to HCV treatment in both low-income ...

CS2011 is a bispecific antibody with high binding affinity to both EGFR and HER3. It effectively blocks downstream signaling of both targets, thereby inhibiting tumor growth on EGFR/HER3 positive ...

A study in mice demonstrated induction of neutralizing antibodies by immunization with cell-culture-derived HCV, providing new possibilities for vaccine development. Akazawa et al. 4 used the ...

Shorter or more flexible hepatitis C treatments are just as effective as standard courses, offering more accessible options for patients. In the first head-to-head comparison of recommended hepatitis ...

Infants are protected by passive immunization via transplacental transfer of maternal antibodies. The IP programs have been effective, and the majority of European countries have adopted this ...

Finally, E2 recognition by SR‐BI was competed out in an isolate‐specific manner both on the hepatoma cell line and on the human SR‐BI‐transfected cell line by an anti‐HVR1 monoclonal antibody. A major ...

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease. Experts from the University of ...